A shear gradient-activated microfluidic device for automated monitoring of whole blood haemostasis and platelet function
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Accurate assessment of blood haemostasis is essential for the management of patients who use extracorporeal devices, receive anticoagulation therapy or experience coagulopathies. However, current monitoring devices do not measure effects of haemodynamic forces that contribute significantly to platelet function and thrombus formation. Here we describe a microfluidic device that mimics a network of stenosed arteriolar vessels, permitting evaluation of blood clotting within small sample volumes under pathophysiological flow. By applying a clotting time analysis based on a phenomenological mathematical model of thrombus formation, coagulation and platelet function can be accurately measured in vitro in patient blood samples. When the device is integrated into an extracorporeal circuit in pig endotoxemia or heparin therapy models, it produces real-time readouts of alterations in coagulation ex vivo that are more reliable than standard clotting assays. Thus, this disposable device may be useful for personalized diagnostics and for real-time surveillance of antithrombotic therapy in clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microfluidic perfusion models that are used to model early stage atherosclerosis and later thrombosis have a significant potential in drug development [291–294].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [293]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane)
Duffy, D. C., McDonald, J. C., Schueller, O. J. A., & Whitesides, G. M. (1998) · Analytical Chemistry · doi:10.1021/ac980656z · Cited by 5,288 · cited 7×
“( c ) Photograph of three haemostasis monitoring devices formed in a single piece of PDMS mould on top of a standard glass slide (75 (cid:4) 50mm).”
MethodInfluentialA shear gradient–dependent platelet aggregation mechanism drives thrombus formation
Nesbitt, W. S., Westein, E., Tovar-Lopez, F. J., Tolouei, E., Mitchell, A., Fu, J., Carberry, J., Fouras, A., & Jackson, S. P. (2009) · Nature Medicine · doi:10.1038/nm.1955 · Cited by 862 · cited 3×
“Notably, flow acceleration and deceleration (fluid shear gradients) have been shown to initiate platelet aggregation during arterial thrombosis in vivo 14,15 , and clotting in extracorporeal devices usually occurs at sites of sudden flow disturbances, stagnation points and stenosed sections of tubing…”
Animal Models of sepsis: setting the stage
Buras, J. A., Holzmann, B., & Sitkovsky, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1854 · Cited by 843 · cited 1×
“…by intravenous infusion of lipopolysaccharide (LPS) are widely used to study disruption of haemostasis and intravascular coagulation owing to sepsis 33 Therefore, we first injected a lethal dose of LPS intravenously to the pig for 90 min and then monitored the coagulation state of the animal’s…”
Cho, Y. I., & Kensey, K. R. (1991) · Biorheology · doi:10.3233/bir-1991-283-415 · Cited by 823
A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling
Leslie, D. C., Waterhouse, A., Berthet, J. B., Valentin, T. M., Watters, A. L., Jain, A., Kim, P., Hatton, B. D., Nedder, A., Donovan, K., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3020 · Cited by 758 · cited 2×
“When the blood was filled in a syringe and pushed, the syringe was manually agitated every 2–3min to prevent sedimentation of erythrocytes in the blood.”
Self-citationMicro- and Nanoscale Fluid Mechanics: Transport in Microfluidic Devices
Kirby, B. J. (2010) · Cited by 753
The growing complexity of platelet aggregation
Jackson, S. P. (2007) · Blood · doi:10.1182/blood-2006-12-027698 · Cited by 737 · cited 1×
“As platelet aggregation is a major contributor to the development of vascular occlusion, 29 we further explored if this biomimetic device can be used as a rapid platelet function assay under stenosed flow.”
Ganter, M. T., & Hofer, C. K. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318168b367 · Cited by 677
Hirsh, J., Dalen, J. E., Deykin, D., & Toller, L. (1992) · Chest · doi:10.1378/chest.102.4_supplement.337s · Cited by 558 · cited 2×
“4f) 26 .”
BackgroundExtracorporeal Membrane Oxygenation—Hemostatic Complications
Murphy, D. A., Hockings, L. E., Andrews, R. K., Aubron, C., Gardiner, E. E., Pellegrino, V. A., & Davis, A. K. (2015) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2014.12.001 · Cited by 455
Cited by
Point-of-Care Diagnostics: Recent Developments in a Connected Age
Nayak, S., Blumenfeld, N. R., Laksanasopin, T., & Sia, S. K. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04630 · Cited by 508
Shrivastava, S., Trung, T. Q., & Lee, N.-E. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00319c · Cited by 497
Jain, A., Barrile, R., van der Meer, A., Mammoto, A., Mammoto, T., De Ceunynck, K., Aisiku, O., Otieno, M., Louden, C., Hamilton, G., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.742 · Cited by 325
“Additionally, we found that this PBD index increased when we raised the hemodynamic shear rate from 275 s to 750 s in the microfluidic channel (by altering pumping rates), indicating a higher tendency to form platelet-rich thrombi and promote platelet-endothelial binding interactions in vitro (Figure 2d), as reported…”
ResultSelf-citationShear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities
Rana, A., Westein, E., Niego, B., & Hagemeyer, C. E. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00141 · Cited by 226
SERS-based microdevices for use as in vitro diagnostic biosensors
Lee, S., Dang, H., Moon, J.-I., Kim, K., Joung, Y., Park, S., Yu, Q., Chen, J., Lu, M., Chen, L., et al. (2024) · Chemical Society Reviews · doi:10.1039/d3cs01055d · Cited by 220
Metadata
- Authors
- Jain, A., Graveline, A., Waterhouse, A., Vernet, A., Flaumenhaft, R., & Ingber, D. E.
- Affiliations
- Boston Children's Hospital (US)
- Harvard University (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Ingber, Donald E.
- ORCID
- Venue
- Nature Communications
- Published
- 2016-01-06
- Volume
- 7
- Issue
- 1
- Pages
- 10176-10176
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4729824
- OpenAlex
- W2343360984
- Cited by
- 182
- References
- 47
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 20 · 2023: 18 · 2022: 12 · 2021: 14 · 2020: 28 · 2019: 22 · 2018: 15 · 2017: 18 · 2016: 11
- FWCI
- 19.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Foundation (ECS- 03-35765, 0335765)
- Harvard University (ECS-0335765)
- National Institutes of Health (ECS-0335765)
- Defense Advanced Research Projects Agency (N66001‐11‐1‐4180, HR0011, HR0011-13-C-0025)
- Hansjörg Wyss Institute for Biologically Inspired Engineering, Harvard University
- National Heart, Lung, and Blood Institute (R01HL125275, R01HL112809, T32HL007917)
- Topics
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- platelet function, microfluidics, shear gradient, thrombus formation, coagulation, extracorporeal circuit, anticoagulation, heparin, endotoxemia, coagulopathy, personalized diagnosis
- MeSH terms
- Abciximab, Animals, Antibodies, Monoclonal, Blood Coagulation Tests, Blood Platelets, Female, Hemostasis, Humans, Immunoglobulin Fab Fragments, Platelet Aggregation, Platelet Aggregation Inhibitors, Platelet Function Tests, Swine, Point-of-Care Systems, Shear Strength, Microfluidic Analytical Techniques, Lab-On-A-Chip Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.